Service de chirurgie et cancérologie digestive, CHU Carémeau, place Robert-Debré, 30009 Nîmes cedex 9, France.
J Visc Surg. 2011 Dec;148(6):e435-41. doi: 10.1016/j.jviscsurg.2011.10.006. Epub 2011 Nov 29.
The prevalence of parastomal hernia (PSH) varies considerably in the literature. This condition impacts negatively on quality of life. Yet there is no surgical consensus concerning treatment. The aim of the study was to determine treatment and recurrence rates of PSH in a large population of ostomy patients.
This retrospective study was carried out by a self-administered questionnaire in a population drawn at random from the database of the French federation of ostomy patients (FSF).
Seven hundred and eighty-two patients were eligible for the study. The mean duration of follow-up was 10.5 years. PSH was reported by 202 patients (25.6%) and appeared on average 18 months after creation of the stoma. In multivariate analysis, ileostomy had a lower risk of developing PSH than did colostomy; age mote than 60 years and peristomal complications at the time of stoma creation increased the risk. Only 24% of patients with PSH were free from symptoms related to the hernia. The main complaints were pain (35%), difficulties in fitting a stomal appliance with leakage (28%); 114 patients (56%) underwent operative repair. The morbidity rate of reoperation was 33%, and 57 patients (52%) had recurrence of PSH within an average of 6 months. Transposition of the stoma to another location and the use of prosthetic mesh decreased recidivism AF recurrence?
PSH aggravates the inherently diminished quality of life of stoma patients. There are many proposed surgical treatments but recurrence occurs in more than half of patients. Randomized trials on the treatment of PSH are nonexistent. The use of a prosthetic mesh may reduce the risk of recurrence. The prophylactic use of prophylactic mesh at the time of initial stoma formation is a strategy worthy of consideration.
文献中报道的造口旁疝(PSH)患病率差异较大。这种情况会对生活质量产生负面影响。然而,针对治疗方法尚未达成外科共识。本研究旨在确定在一大群造口患者中 PSH 的治疗和复发率。
这项回顾性研究通过对法国造口患者联合会(FSF)数据库中的随机人群进行自我管理问卷调查进行。
782 名患者符合研究条件。平均随访时间为 10.5 年。202 名患者(25.6%)报告了 PSH,平均在造口后 18 个月出现。多变量分析显示,与结肠造口术相比,回肠造口术发生 PSH 的风险较低;年龄大于 60 岁和造口时的围手术期并发症增加了风险。仅有 24%的 PSH 患者无疝相关症状。主要抱怨是疼痛(35%)、造口器具 fitting 和渗漏困难(28%);114 名患者(56%)接受了手术修复。再次手术的发病率为 33%,平均 6 个月内有 57 名患者(52%)复发 PSH。将造口转移到另一个位置和使用假体网片可降低复发率。复发?
PSH 加重了造口患者本已降低的生活质量。有许多提议的手术治疗方法,但超过一半的患者会复发。针对 PSH 的治疗尚无随机试验。在初次造口时使用假体网片可能会降低复发的风险。预防性使用预防性网片是一种值得考虑的策略。